9Chapter AI · 九章源起

Protein
TherapeutiX

Engineering the future of protein therapeutics with AI that surpasses the boundaries of structural biology.

Explore Our Science

Science at the frontier

Two foundational platforms powering our pursuit of programmable protein therapeutics.

Foundation Model

Structure Prediction Beyond AlphaFold3

Next-generation biomolecular foundation models delivering superior accuracy in protein structure prediction. Powered by the Protenix family of open-source models, pushing the frontier of computational structural biology.

Design Pipeline

Experimentally Validated Antibody Design

End-to-end AI-driven antibody design pipeline with industry-leading success rates, validated through wet-lab experiments. From target to therapeutic candidate, accelerated by generative AI.

Built by scientists

A team at the intersection of machine learning and molecular biology.

Co-founder & CEO

Wenzhi Xiao

肖文之

Pioneered AI for Science at ByteDance since 2021, building next-generation biomolecular foundation models. Creator of the Protenix family. Previously built AI models for recommendation and advertising systems.

Co-founder

Xinshi Chen

陈心诗

Ph.D. in Machine Learning from Georgia Tech. Research spans biomolecular structure prediction, protein design, and learning-based algorithm design. Previously at Facebook AI, MBZUAI, and Oak Ridge National Lab.

 

Yuxuan Zhang

张宇轩